HTR1A and schizophrenia: Mamo et al. (23) quantified aripiprazole binding to three different receptor types in 12 patients with schizophrenia, who were treated with aripiprazole doses between 10 and 30 mg daily: D2/3 dopamine (with [11C]raclopride), 5-HT2 serotonin (with [18F]setoperone), and 5-HT1A (with [11C]WAY100635).